doi: 10.3389/fendo.2023.1178486 Received 02 March 2023 Accepted 09 June 2023 Published 04 July 2023 Volume 14 - 2023 Edited by Goo Jun, University of Texas Health Science Center at Houston, United States Reviewed by Pik Fang Kho, Stanford University, United States
Food and Drug Administration: FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss Harvard Health Publishing: Understanding New Weight Loss Drugs The New England Journal of Medicine : TripleHormone-Receptor Agonist Retatrutide for Obesity a Phase 2 Trial Yale Medicine: GLP-1 Weight-Loss Pills: What You Need to Know FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss
Supplementing with 30 mL of MCT three times daily provides 630 kcal, which is about 30% of a typical persons daily energy requirement and up to 50% of daily lipids
A., Burdett, E., Mohan, H., Bhattacharjee, A., Gunderson, E
Regulation of peroxisomal lipid metabolism: the role of acyl-CoA and coenzyme A metabolizing enzymes
